Lancet Oncology (online) (2023). H Mehanna, M Taberna, C von Buchwald, S Tous, J Brooks, M Mena, . . . The HNCIG-EPIC group. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. doi: https://doi.org/10.1016/S1470-2045(23)00013-X.
Clin Otolaryngol Online doi: 10.1111/coa.13966 (2022). James TW, MJ Edwards, H Nieto, H Mehanna, P Pracy, C Jennings, . . . P Nankivell. An external validation of C-reactive protein reduction as a predictor of healing following laryngopharyngectomy.
Lancet 397:387-397 (2021). Bhangu A and Global Surgery Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.
European Urology 80:12-15 (2021). Bryan RT, W Liu, SJ Pirrie, R Amir, J Gallagher, AI Hughes, . . . P Patel, ND James. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
Comput Med Imaging Graph 88:101853 (2021). Fouad S, G Landini, M Robinson, TH Song and H Mehanna. Human papilloma virus detection in oropharyngeal carcinomas with in situ hybridisation using hand crafted morphological features and deep central attention residual networks.
Oral Oncology 113:105112 (2021). Vreugdenhil M, C Fong, P Sanghera, A Hartley, J Dunn and H Mehanna. Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.
Int J Molecular Science 218229 (2020). Payne K, M Pugh, J Brooks, N Batis, G Taylor, P Nankivell and H Mehanna. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
J Clin Oncol JCO2001933 (2020). Glasbey JC, A Bhangu and COVIDSurg Collaborative. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Lancet 395:417-426 (2020). Bhangu A and Reinforcement of Closure of Stoma Site (ROCSS) Collaborative and West Midlands Research Collaborative. Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial.
Lancet Child Adolesc Health 4:271-280 (2020). Bhangu A and Rift Study Group on behalf of the West Midlands Research Collaborative. Appendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation study.
Lancet 396:27-38 (2020). Bhangu A and COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
Br J Surg (2020) doi: 10.1002/bjs.11746. Bhangu A and COVIDSurg Collaborative. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.
Br J Surg (2020) doi: 10.1002/bjs.11646. Bhangu A and COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic.
J Clin Oncol 38:2552-2557 (2020). Mehanna H, D Rischin, SJ Wong, V Gregoire, R Ferris, J Waldron, . . . S Porceddu. De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.
BMJ Open 10:e033009 (2020). Kong A, J Good, A Kirkham, J Savage, R Mant, L Llewellyn, . . . H Mehanna. Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol.
Ann Oncol 30:456-463 (2019). Spiteri I, G Caravagna, GD Cresswell, A Vatsiou, D Nichol, A Acar, . . . C Watts, A Sottoriva. Evolutionary dynamics of residual disease in human glioblastoma.
N Engl J Med 374:1444-1454 (2016). Mehanna H, WL Wong, CC McConkey, JK Rahman, M Robinson, AG Hartley, . . . P-NTM Group. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Lancet 386:249-257 (2015). Kehoe S, J Hook, M Nankivell, GC Jayson, H Kitchener, T Lopes, . . . AM Swart. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.